Question 1

What is Mineralys Therapeutics?

Accepted Answer

Mineralys Therapeutics is a biopharmaceutical company focused on improving outcomes for people managing hypertension, chronic kidney disease (CKD), and related diseases that are driven by dysregulated aldosterone.

Question 2

What is the company's approach?

Accepted Answer

Mineralys Therapeutics takes a targeted approach to the control of hypertension, leveraging the latest scientific understanding of the importance of aldosterone in cardio-renal-metabolic diseases.

Question 3

What is the company's lead product candidate?

Accepted Answer

Mineralys Therapeutics' lead product candidate is lorundrostat, a novel, highly selective aldosterone synthase inhibitor that is being developed to treat hypertension and related cardio-renal-metabolic diseases.

Question 4

What is the company's pipeline?

Accepted Answer

In addition to lorundrostat, Mineralys Therapeutics has a pipeline of product candidates focused on targeting aldosterone and improving outcomes for patients with hypertension, CKD, and related conditions.

Question 5

What is the company's culture and values?

Accepted Answer

Mineralys Therapeutics is committed to a culture of innovation, collaboration, and a relentless pursuit of improving the lives of patients. The company's values include a focus on science, a dedication to its mission, and a commitment to ethical and responsible practices.

Mineralys Therapeutics

Company Overview

Company Name

Address

Website

Phone

Employees

About Mineralys Therapeutics

Frequently Asked Questions about Mineralys Therapeutics

What is Mineralys Therapeutics?

What is the company's approach?

What is the company's lead product candidate?

What is the company's pipeline?

What is the company's culture and values?

Technologies Used

Social Profiles

Key Decision Makers